We studied 125~-insulin total and non-specific binding(1B) and 3~-deoxyglucose uptake (Gu) by 30d isolated fetal rabbit-brain cells (viability of >93%;n=8), to define the significance of the IR in the fetal brain. IB and Gu by brain cells were also assessed in the presence of lOmM phenylarsine oxide (PA) (n=4; prevents IR internalization) and 10vM chloroquin (CQ) (n=5; a lysosomotropic agent), to study the internalization and intracellular degradation of the IR (extracellular degradation was constant throughout the study). Peak specific IB per 6 . 4~1 0~ cells was achieved by 1-3 min (2.74+0.18%, X S E M ) , declining by 20 min (0.48+0.15;p<0.001). A decrease in the peak binding was observed with PA (0.40f0.08;p~0.001), whereas CQ resulted in a peak IB of 1.32+0.19, with no decline in IB at 20 min (2.11+0.49;p<0.01). 1x10=~11 insulin increased the Gu from 0.03+0.002to 0.05fP03nM/ 6 . 4~1 0~ cells (p<0.01). PA inhibited Gu and the insulin induced increase in Gu by the brain cells, while CQ inhibited the insulin induced increase in Gu alone (0.02+0.0007;p~0.01). Summary: 1)In the presence of PA, IB is decreased 2)CQ delayed the decline in peak IB secondary to its lysosomotropic effects and decreased intracellular IR degradation 2)Insulin augmented Gu by fetal brain cells 4)Inhibition of IR internalization by PA or lysosomotropic effects by CQ interfered with the insulin induced Gu by the brain cells. We conclude that the insulin induced Gu by fetal brain cells is associated with internalization of the IR.
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Galactose-1-phosphate uridlytransferase (Gal-1-PUT) deficiency i s an inborn e r r o r of metabolism transmitted as an autosomal recessive t r a i t . Gal-1-PUT Screening was performed in a l l the newborns delivered a t Hubbard Hospital of Meharry Medical College f o r an e a r l y detection of t h i s deficiency. The appearance of fluorescent NADPH a f t e r incubating the blood spot with Gal-1-P, UOPG and NADP was used a s a screening t e s t . 2134 newborns were screened during May 1979 -Sept. 1984 . Three abnormal t e s t s were detected i n i t i a l y . After repeating the screening t e s t and quantitating the Gal-1-PUT, one case of t h i s deficiency was established. Two f a l s e positives were presumably due t o i n s u f f i c i e n t blood on the spot. This p a t i e n t i s a f u l l term f i r s t born male t o a Black mother. Gal-1-PUT was quantitated i n erythrocytes by UDPG consumption t e s t . The p a t i e n t had 1.6 u n i t s of a c t i v i t y , however, mother and her brother had 10.7 and 6.4 units respectively. U t i l i z a t i o n of one micromole of UDPG per gram hemoglobin per hour i s defined a s one u n i t . Patient was placed on modified galactose f r e e d i e t and successfully t r e a t e d . His growth and development a r e within normal l i m i t s f o r h i s age. Several variants of Gal-1-PUT deficiency have been reported. The black v a r i a n t of t h i s deficiency has an extensive capacity f o r the galactose metabolism. Incidence of t h i s variant i s extremely rare. I d e n t i f i c a t i o n of a black p a t i e n t a t our hospital, which serves a predominantly black community i s an i n t e r e s t i n g observation. The sorbitol accumulation in the MD embryos was increased compared to the N embryos at all times studied (gestational days 11-15). Moreover, sorbitol levels appeared to be further increased (not statistically significant) in the malformed compared to the non-malformed embryos from the MD rats.
This study demonstrates that offspring of diabetic mothers may accumulate high levels of sorbitol during organogenesis, indicative of a functioning aldose reductase system. This animal model may therefore serve as a useful tool to further investigate the possible relationship between disturbed metabolism of polyols and teratogenesis in diabetic pregnancy. The turnover rate of glucose (GPR), lactate (LPR) and incorporation of lactate carbon into glucose were quantified on the first post-natal day in 10 normal, 4 small-for-gestational age (SGA) and 3 infants of diabetic mothers (IDM). They were either studied prior to feeding or at least 4 hours after the last feed. 
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The lactate turnover in the human newborn is increased compared with adults, reflecting increased glycolysis and increased oxygen consumption. Maternal diabetes and intrauterine growth retardation did not effect lactate turnover or its incorporation into glucose. Lactate incorporation into glucose represents only a small component of total glucose produced in the human neonate. To measure t h e e f f e c t of a reduction of i n s u l i n concentration on ovine f e t a l glucose and oxy en metabolism, we measured glucose (G), i n s u l i n ( I ) , oxygen 70 ) concentrations ( n = l l ) , oxygen and glucose (GUp) uptakes2from the lacenta ( n = l l ) gluc(:zpiroduction (GPr) and u t i l i z a t i o n ( G U~P (n=10), and gfucose oxidation (GOx)(n=8) r a t e s before and a f t e r reducing f e t a l insul in concentration with streptozotocin. 016 These r e s u l t s demonstrate t h a t a reduction in f e t a l i n s u l i n concentration r e s u l t s in: reduced f e t a l glucose u t i l i z a t i o n (p< 0.05) accounted f o r by a f a l l in both glucose oxidation (0.91 mg/min/kg) and the disposal of glucose by non-oxidative pathways (0.44 mg/min/kg); increased f e t a l endogenous glucose production (p< 0.01) producing hyper lycemia; and reduced f e t a l glucose uptake from the placenta Qp < 0.001). Thus the basal level of insulin suppresses f e t a l endogenous glucose production, increases glucose u t i 1 i z a t i o n , decreases f e t a l glucose concent r a t i o n , and increases f e t a l glucose uptake from the placenta. and alkaline phos-2.2 phatase(AP). Bone mineral content(BMC) and bone width(BW) were determined on the radius at 8 and 16 wks. Serum levels of PO&, PTH,1,25(OH)2D and AP increased in infants following birth and remained elevated throughout the study. Infants supplementedwith vitamin D2,D3 or 25(OH)D3 demonstrated a corresponding rise in the 25(OH) and 24,25(0H)2 metabolites. However, supplemental vitamin D2,D3 or 25(OH)D3 demonstrated different abilities to elevate the infant's 250HD status. On a weight basis, 250HD3 was most effective at increasing the infant's 250HD status(ll.6ng 250HD3/ml serumflug 250HD3 intake) followed by D3(2.10ng 250HD3/ ml serumllug D3 intake) and D2(1.15ng 250HD2/ml serum/lpg D2 intake). The infants demonstrated a substrate-product relationship for Dj vs 250HD3(r=.7,p<.001), D2 vs 250HD2(r=.8,p<.001), 250HD2 vs 24,25(OH)2D2(r=.7,p<.001) and 250HD3 vs 24,25(OH)2D3(r=.6, p<.001). 250HD and 1,25(0H)~D serum levels did not correlate in infant serum. Serum aft levels demonstrated an inverse correlation(-.22,p<.05) with serum 24,25(OH)2D levels indicating a possible role of this metabolite in Ca homeostasis of the rapidly growing infant. BMC remained constant in all infants although BW increased between 8 and 16 weeks.
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